M. Berhoune

Absence of significant clinical benefit for a systematic routine creatine phosphokinase measurement in asymptomatic patients treated with anti-programmed death protein (ligand) 1 immune checkpoint inhibitor to screen cardiac or neuromuscular immune-related toxicities.

C. Robert, S. Ederhy, B. Besse, 2021, European journal of cancer.

FabAct®: a decision-making tool for the anticipation of the preparation of anticancer drugs.

Ludovic-Alexandre Vidal, Evren Sahin, Nicolas Martelli, 2010, Journal of evaluation in clinical practice.

Therapeutic Strategy for Treatment of Metastatic Non-Small Cell Lung Cancer

S. Oudard, F. Scotté, P. Prognon, 2008, The Annals of pharmacotherapy.

The application of hazard analysis and critical control points and risk management in the preparation of anti-cancer drugs.

Nicolas Martelli, Patrice Prognon, Malik Berhoune, 2009, International journal for quality in health care : journal of the International Society for Quality in Health Care.

Applying AHP to select drugs to be produced by anticipation in a chemotherapy compounding unit

Ludovic-Alexandre Vidal, Evren Sahin, Nicolas Martelli, 2010, Expert Syst. Appl..

Stability of Oxaliplatin Solution

R. Farinotti, A. Bellanger, C. Fernandez, 2009, The Annals of pharmacotherapy.

The application of hazard analysis and critical control points and risk management in the preparation of anti-cancer drugs.

P. Prognon, N. Martelli, L. Havard, 2009, International journal for quality in health care : journal of the International Society for Quality in Health Care.